You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
There was a question about how the GitHub repositories are organized under the R-universe project. Note that the package repos may be reached via https://pharmaverse.r-universe.dev/ui#packages or through https://github.com/pharmaverse/. SK said that he would confer with the pharmaverse council and provide more information about the project at a later time.
There was a question about how the GitHub repositories are organized under the R-universe project
Github repos aren't organised under any banner by design - e.g. they can have a repo in the pharmaverse org, but right now that's more limited to a handful of repos. Some are developed in company owned repos (e.g. Roche's insightsengineering and Roche orgs, as well as Atorus' org, Merck's etc).
Right now we just track the packages that are part of the pharmaverse in r-universe as a convenience thing (e.g. if testing). I would assume no company would depend on r-universe (or CRAN) as we all have internal cran-like mirrors we distribute from internally (e.g. Roche uses RSPM). The FDA has also accepted OS packages from github repos (although may prefer CRAN).
The text was updated successfully, but these errors were encountered:
Thank you @epijim. This makes things much more clear with regards to access and organization.
However, I am still not clear about the purpose of the pharmaverse, the practical benefits of branding a package as part of the pharmaverse, and about guarantees that are conferred on packages because they are part of the pharmaverse.
@joseph-rickert for:
There was a question about how the GitHub repositories are organized under the R-universe project
Github repos aren't organised under any banner by design - e.g. they can have a repo in the pharmaverse org, but right now that's more limited to a handful of repos. Some are developed in company owned repos (e.g. Roche's
insightsengineering
andRoche
orgs, as well as Atorus' org, Merck's etc).Right now we just track the packages that are part of the pharmaverse in r-universe as a convenience thing (e.g. if testing). I would assume no company would depend on r-universe (or CRAN) as we all have internal cran-like mirrors we distribute from internally (e.g. Roche uses RSPM). The FDA has also accepted OS packages from github repos (although may prefer CRAN).
The text was updated successfully, but these errors were encountered: